Cancer Therapy News and Research

RSS

Findings provide a step towards personalized cancer therapy

Oxford University researchers have found the Achilles heel of certain cancer cells - mutations in a gene called SETD2. Their findings will be presented to the National Cancer Research Institute conference in Liverpool this Monday (2 Nov 15).

2 Nov 2015

Covered California kicks off advertising campaign to encourage enrollment in affordable health insurance

Kicking off a 38-stop bus tour of hospitals, clinics and storefronts where Californians can enroll in affordable health insurance, Covered California began spotlighting iconic buildings and hundreds of enrollment locations across the state today.

31 Oct 2015

New campaign raises awareness of City of Hope's life-saving mission and impact

Imagine being diagnosed with one of the most rare and aggressive forms of breast cancer, given a five percent chance to live and told having children will never be an option. Southern California local Kommah McDowell was told just that— and then she went to City of Hope.

31 Oct 2015

New TSRI study highlights urgent need for new treatments to fight growing cancer metastases

A new study from scientists at The Scripps Research Institute helps explain why cancer metastasis is so hard to stop.

29 Oct 2015

Drug that relieves opioid-induced constipation may help some cancer patients live longer

Patients with advanced cancers who took a drug designed to relieve constipation caused by pain killers lived longer and had fewer reports of tumor progression than cancer patients who did not receive the drug, according to results presented October 27 at the 2015 meeting of the American Society of Anesthesiologists in San Diego. This is the first study in humans to associate opioid blockade with improved survival.

28 Oct 2015

New method to grow 3D pancreatic cancer organoid may help test drug responses and personalized treatments

The development of a new method to grow three-dimensional organoid cultures of pancreatic tumors directly from patients' surgical tissue offers a promising opportunity for testing targeted therapies and drug responses and personalizing treatments in a rapid, cost-effective manner.

28 Oct 2015

ISIBELa joint research project aims to improve cancer therapy

Some individuals experience cancer recurrence when they enter adolescence or adulthood after they have been successfully treated for cancer in childhood while others don't. But why is this? This is the core question being considered in a research project directed by the University Medical Center of Johannes Gutenberg University Mainz.

27 Oct 2015

Unique, tiny protein cage developed to deliver chemotherapy chemicals directly to cancer cells

Washington State University researchers have developed a unique, tiny protein cage to deliver nasty chemotherapy chemicals directly to cancer cells. Direct delivery could improve treatment and lessen what can be horrendous side effects from toxic drugs.

27 Oct 2015

UW researcher reveals how cancer diagnosis affects employment, income of individuals and families

A new analysis by University of Wyoming researcher Anna Zajacova indicates that when American adults are diagnosed with cancer, they experience significant decreases in the probability of working, in the number of hours they work and, correspondingly, in their incomes.

26 Oct 2015

Lilly expands existing immuno-oncology collaboration with AstraZeneca

Eli Lilly and Company today announced an extension to their existing immuno-oncology collaboration exploring novel combination therapies for the treatment of patients with solid tumors.

22 Oct 2015

APBI brachytherapy improves overall survival in selected patients with early stage breast cancer

The Groupe Européen de Curiethérapie European Society for Therapeutic Radiology and Oncology (GEC-ESTRO) today announced results from a prospective, randomized, multicenter phase III study comparing accelerated partial breast irradiation (APBI) with interstitial multicatheter brachytherapy to whole breast irradiation (WBI).

20 Oct 2015

DelMar reports positive data from preclinical study of VAL-083 for treatment of ovarian cancer

DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of new cancer therapies, announced that yesterday it presented positive preclinical data demonstrating the promising potential of its lead product candidate VAL-083 (dianhydrogalactitol) as a treatment for ovarian cancer.

19 Oct 2015

Nanodiamonds may improve outcomes for patients undergoing root canals

People undergoing root canals may have gained a powerful, if tiny, new ally. Researchers from the UCLA School of Dentistry have found that using nanodiamonds to fortify a material used in the procedure could significantly improve outcomes for patients.

19 Oct 2015

ViewRay obtains Korean regulatory approval for MRI-guided radiation therapy system

ViewRay, Inc. announced today that the company has received regulatory approval from the Ministry of Food and Drug Safety (MFDS) – formerly known as the Korean Food and Drug Administration – to sell its ViewRay system in Korea. On October 13, 2015, the first patient treatments commenced less than four weeks after the system completed installation at Seoul National University Hospital, a leading healthcare facility in Korea.

18 Oct 2015

New research raises hope for novel cancer immunotherapy

New research by Dana-Farber Cancer Institute scientists raises the prospect of cancer therapy that works by converting a tumor's best friends in the immune system into its gravest enemies.

16 Oct 2015

Antibiotic resistance potentially threatens the safety and efficacy of surgical procedures and immunosuppression therapies

This week The Lancet Infectious Diseases journal published the strongest evidence to date that increasing antibiotic resistance could have disastrous consequences for patients undergoing surgery or cancer chemotherapy. Based on a review of published literature, researchers predict that a 30% reduction in the efficacy of the prophylactic antibiotics routinely given when these procedures are performed could result in 120,000 more infections and 6300 infection-related deaths every year in the USA alone.

16 Oct 2015

Medical experts launch crowd funding project to investigate effect of malaria drug on colorectal cancer

Medical experts investigating whether a common malaria drug could have a significant impact on colorectal cancer have launched a crowd funding project to fund their work.

16 Oct 2015

CWRU investigator receives $2.82 million NIH grant to make stealth bombs for brain cancer treatment

A Case Western Reserve University researcher has received a 5-year, $2.82 million National Institutes of Health grant to make, in essence, stealth bombs that slip past the brain's defenses to attack an incurable form of cancer.

15 Oct 2015

New blood test could help pair cancer patients with suitable therapy for their disease

CANCER RESEARCH UK-funded scientists have developed a blood test that could help pair cancer patients with the most suitable therapy for their disease and then track the tumour's progress to see if the treatment is working, according to research published today (Thursday) in Clinical Cancer Research.

15 Oct 2015

OncoSec reports net loss of $6.5 million for fourth quarter of fiscal 2015

OncoSec Medical Incorporated, a company developing DNA-based intratumoral cancer immunotherapies, today announced financial results for the fourth quarter and fiscal year ended July 31, 2015.

15 Oct 2015

Cancer Therapy News and Research

Findings provide a step towards personalized cancer therapy

Covered California kicks off advertising campaign to encourage enrollment in affordable health insurance

New campaign raises awareness of City of Hope's life-saving mission and impact

New TSRI study highlights urgent need for new treatments to fight growing cancer metastases

Drug that relieves opioid-induced constipation may help some cancer patients live longer

New method to grow 3D pancreatic cancer organoid may help test drug responses and personalized treatments

ISIBELa joint research project aims to improve cancer therapy

Unique, tiny protein cage developed to deliver chemotherapy chemicals directly to cancer cells

UW researcher reveals how cancer diagnosis affects employment, income of individuals and families

Lilly expands existing immuno-oncology collaboration with AstraZeneca

APBI brachytherapy improves overall survival in selected patients with early stage breast cancer

DelMar reports positive data from preclinical study of VAL-083 for treatment of ovarian cancer

Nanodiamonds may improve outcomes for patients undergoing root canals

ViewRay obtains Korean regulatory approval for MRI-guided radiation therapy system

New research raises hope for novel cancer immunotherapy

Antibiotic resistance potentially threatens the safety and efficacy of surgical procedures and immunosuppression therapies

Medical experts launch crowd funding project to investigate effect of malaria drug on colorectal cancer

CWRU investigator receives $2.82 million NIH grant to make stealth bombs for brain cancer treatment

New blood test could help pair cancer patients with suitable therapy for their disease

OncoSec reports net loss of $6.5 million for fourth quarter of fiscal 2015

Your guide to microplate readers for cancer research eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News